Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon

Boston Sci to cut staff after sales decline

Boston Scientific has reported a decline in fourth quarter and year-end sales, as well as an anticipated staff reduction that could affect as many as 1,000 employees. 

BioFreedom stent approved in Europe

BioFreedom, a polymer-free drug-coated stent, has received CE Mark approval in Europe.

Carotid stenting appears safe in high-risk patients

There was no evidence that the presence of a contralateral carotid artery occlusion was associated with an increased risk of inhospital death, nonfatal MI or nonfatal stroke in patients undergoing elective carotid artery stenting, based on inhospital outcomes in the CARE Registry.

Left radial access may reduce operator’s radiation exposure

The radiation dose absorbed by operators was significantly lower in physicians who performed radial coronary interventions via the left artery compared with physicians who used the right artery. That was the finding of a randomized trial published online Jan. 23 in the Heart.

Drug-eluting balloons may be more effective than DES for restenosis

In a meta-analysis of five recent trials, researchers found that treating in-stent restenosis with drug-eluting balloons (DEB) reduced the risk of major adverse cardiac events when compared with plain balloon angioplasty or restenting with a Taxus Liberte drug-eluting stent (DES). The results were published online Jan. 18 in Heart.

Thumbnail

Incomplete revascularization leads to adverse outcomes, w/wo total occlusions

Within the PCI and CABG arms of the All-Comers SYNTAX trial, incomplete revascularization that is angiographically determined has a detrimental impact on long-term clinical outcomes, including mortality. This effect remained consistent in patients with and without total occlusions, according to the study authors.

ACC unveils 2013 late-breakers

The American College of Cardiology (ACC) has released its lineup of late-breaking clinical trials that will be featured at its 2013 annual scientific meeting, March 9 through 11 in San Francisco. Cardiovascular Business will be there to bring you daily coverage of the presentations.

IABP in elective high-risk PCI may offer long-term benefit

A trend toward improved mortality at six months in patients with severe ischemic cardiomyopathy who received elective intra-aortic balloon pump (IABP) support during PCI appears to persist in a long-term analysis of the BCIS-1 trial. The five-year outcome results put in focus the need for longer-term follow-up for these devices, according the authors of an accompanying editorial.

Displaying 1913 - 1920 of 2712

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.